Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study - Kerstjens, H AM; Maspero, J; Chapman, K R (Lancet Respir Med, 2020)
et al.